| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/15/2000 | US6025487 Reacting 2-(4-azetidin-2-one)-cyclohexanone derivatives with sterically hindered organic base in presence of lewis acid |
| 02/15/2000 | US6025474 Isolated nucleic acid molecules coding for tumor rejection antigen precursor mage-3 and uses thereof |
| 02/15/2000 | US6025466 With antitumor activity |
| 02/15/2000 | US6025401 Method and agents for inhibiting protein aging |
| 02/15/2000 | US6025400 Compositions for treatment of antibiotic-resistant gram-positive bacterial infections and methods for using and preparing the same |
| 02/15/2000 | US6025399 Method of producing neuromuscular block by the use of tetra-propyl or tetrabutylammonium compounds |
| 02/15/2000 | US6025398 Benzamidoxime prodrugs as antipneumocystic agents |
| 02/15/2000 | US6025396 Stable prostaglandin E1-containing injectable composition |
| 02/15/2000 | US6025395 Method of preventing or delaying the onset and progression of Alzheimer's disease and related disorders |
| 02/15/2000 | US6025394 Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols |
| 02/15/2000 | US6025393 Bucillamine exhibits an excellent suppressive effect on disorders of the mucous membrance and exhibits a therapeutic effect on ulcerative colitis. |
| 02/15/2000 | US6025392 substituted tetrahydrofuran analogs of prostaglandins as ocular hypotensives |
| 02/15/2000 | US6025391 Enteric-coated pharmaceutical compositions of mycophenolate |
| 02/15/2000 | US6025390 Heteroaromatic pentadienoic acid derivatives useful as inhibitors of bone resorption |
| 02/15/2000 | US6025389 A mineral oil, one or more fatty alcohols or fatty esters, a polyoxyethylene ether or ester surfactant, xanthan gum, water and a method for treating a bacterial infection using said composition. |
| 02/15/2000 | US6025388 Method for inhibiting gene expression promoted by AP1 protein with RARβ selective retinoids and method for treatment of diseases and conditions with such retinoids |
| 02/15/2000 | US6025387 Gastroprotective flavone/flavanone compounds with therapeutic effect on inflammatory bowel disease |
| 02/15/2000 | US6025382 Antithrombotic diamines |
| 02/15/2000 | US6025381 3,4-(diphenyl)chromans |
| 02/15/2000 | US6025380 Medicament |
| 02/15/2000 | US6025379 Methods of treating or preventing interstitial cystitis |
| 02/15/2000 | US6025378 Antiatherosclerotic action. |
| 02/15/2000 | US6025377 1h-1,2,4-triazole derivative. these compounds can also be used to treat viral infections. |
| 02/15/2000 | US6025376 Chiral methylphenyloxazolidinones |
| 02/15/2000 | US6025375 4,5-diaryloxazole derivatives |
| 02/15/2000 | US6025374 Migraine |
| 02/15/2000 | US6025373 Decreasing fibrinogen levels without undohypo-coagulation, |
| 02/15/2000 | US6025372 Somatostatin agonists |
| 02/15/2000 | US6025369 N-methyl-D-aspartate (NMDA) receptor blockers for the prevention of atherosclerosis |
| 02/15/2000 | US6025365 Chelerythrine and radiation combined tumor therapy |
| 02/15/2000 | US6025364 Method of treating asthma |
| 02/15/2000 | US6025363 Composition for suppressing appetite |
| 02/15/2000 | US6025362 Utilized to accelerate anesthetic recovery from the effects of certain compounds as propofol, etomidate, barbiturates, |
| 02/15/2000 | US6025361 Effective pde iv inhibitors, asthma |
| 02/15/2000 | US6025360 Use of theophylline for the manufacture of a medicament for the treatment of asthma |
| 02/15/2000 | US6025359 Drug resistance and multidrug resistance modulators |
| 02/15/2000 | US6025357 Anthelmintic paste |
| 02/15/2000 | US6025356 Powerful dopaminergic compounds, low level of side effects exhibited. |
| 02/15/2000 | US6025354 Exhibit phosphodiesterase iv inhibition and can be used to treat asthmatic disorders. |
| 02/15/2000 | US6025353 Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents |
| 02/15/2000 | US6025350 C-4" substituted macrolide antibiotics |
| 02/15/2000 | US6025349 Phenyl.-substituted alkenylcarboguanidides carrying perfluoroalkyl groups, a process for their preparation, their use as a medicament or diagnostic agent, and also a medicament containing them |
| 02/15/2000 | US6025348 Which lowers the blood cholesterol level of a person having a high cholesterol level when used in daily life, diacylglycerol |
| 02/15/2000 | US6025346 1α-hydroxy vitamin D4 and novel intermediates and analogues |
| 02/15/2000 | US6025345 Inhibitors of NAALADase enzyme activity |
| 02/15/2000 | US6025344 Certain dioic acid derivatives useful as NAALADase inhibitors |
| 02/15/2000 | US6025343 Lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs |
| 02/15/2000 | US6025340 Surface expression of enzyme in gene directed prodrug therapy |
| 02/15/2000 | US6025339 Oligo is antisense to the initiation codon, the coding region or the 5' and 3' intronexon junctions of a gene encoding the adenosine a.sub.1 receptor or antisense to an adenosine a.sub.1 receptor mrna; and |
| 02/15/2000 | US6025335 L-deoxyribofuranosyl nucleoside phosphodiester dimers where the sugar moiety or at least one of the nucleosides has an l-configuration, cancer and viral infections, in mammals. |
| 02/15/2000 | US6025331 Pharmaceutical compositions comprising troponin subunits, fragments and analogs thereof and methods of their use to inhibit angiogenesis |
| 02/15/2000 | US6025328 Antitumor agents |
| 02/15/2000 | US6025312 Composition containing aluminum salt of hinokitiol and/or complex compound of hinokitiol with aluminum compound |
| 02/15/2000 | US6025198 Antisense modulation of Ship-2 expression |
| 02/15/2000 | US6025196 Chimeric proteins comprising liver enriched transcription factors and nucleic acids encoding the same |
| 02/15/2000 | US6025180 Asp1 |
| 02/15/2000 | US6025151 Administering compounds to treat a non-swine subject for elevated platelet derived growth factor levels, jun kinase, c-jun or inflammatory cytokines, or activation of nf-kappab or nf-kappab p65 or neutrophil infiltration |
| 02/15/2000 | US6025147 Inhibitors of interleukin-1 β converting enzyme |
| 02/15/2000 | US6025140 Membrane-permeable constructs for transport across a lipid membrane |
| 02/15/2000 | US6024984 Composition containing an extract from muirapuama root and plant worm extract |
| 02/15/2000 | US6024983 Potentiating immunology biocompatible excipients in microcapsules |
| 02/15/2000 | US6024982 Immediate release tablet cores of insoluble drugs having sustained-release coating |
| 02/15/2000 | US6024980 Multiphase soft gelatin dosage form |
| 02/15/2000 | US6024979 Treatment of infections in ruminants with bolus |
| 02/15/2000 | US6024977 Covalent polar lipid conjugates with neurologically active compounds for targeting |
| 02/15/2000 | US6024974 Transdermal drug delivery |
| 02/15/2000 | US6024959 Pharmaceutical composition containing pectin and a phospholipid used as an antidiarrheal and antiulcer agent |
| 02/15/2000 | US6024957 Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same |
| 02/15/2000 | US6024944 Sunsccreen agents and lipids |
| 02/15/2000 | US6024941 Vitamin a and stabilizers |
| 02/15/2000 | US6024940 Antiinflammatory agents for mammals |
| 02/15/2000 | CA2197739C 1,4-dihydropyridine compounds |
| 02/15/2000 | CA2180621C New aminophenylphosphonic acid derivatives; process for preparing the same and pharmaceutical compositions containing them |
| 02/15/2000 | CA2172855C Cholesterol or neutral fat level reducer |
| 02/15/2000 | CA2154730C Synergetic blend compositions between at least one rxr specific ligand and at least one rar- specific ligand; uses thereof |
| 02/15/2000 | CA2152792C Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 02/15/2000 | CA2119218C Enantioselective synthesis of 5,6-dihydro-(s)-4-(ethylamino)-(s)-6-methyl-4h-thieno 2,3-b thiopyran-2-sulfonamide 7,7-dioxide and related compounds |
| 02/15/2000 | CA2109585C Isoxazole and isothiazole compounds that enhance cognitive function |
| 02/15/2000 | CA2105114C Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl)-1- piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one hydrochloride |
| 02/15/2000 | CA2082284C Process for the preparation of 20-oxo 17.alpha.,21-dihydroxylated derivatives of pregnane and new intermediate compounds |
| 02/15/2000 | CA2077461C Inhibition of the formation or activity of human leukocyte 12-lipoxygenase pathway |
| 02/15/2000 | CA2058398C 1,4 benzothiazine-2-acetic acid derivatives, processes for production thereof |
| 02/15/2000 | CA2006008C Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
| 02/15/2000 | CA1340897C 1,2,4-trioxane derivatives |
| 02/12/2000 | CA2248989A1 Novel compounds |
| 02/10/2000 | WO2000007014A2 Leptin-mediated gene-induction |
| 02/10/2000 | WO2000006742A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 02/10/2000 | WO2000006738A2 NUCLEIC ACIDS AND PROTEINS FROM $i(STREPTOCOCCUS PNEUMONIAE) |
| 02/10/2000 | WO2000006736A2 Nucleic acids and proteins from group b streptococcus |
| 02/10/2000 | WO2000006716A1 Growth differentiation factor-11 |
| 02/10/2000 | WO2000006709A1 Human protein kinase h2lau20 |
| 02/10/2000 | WO2000006705A2 Genetically modified cd34-negative adherently growing stem cells and their use in gene therapy |
| 02/10/2000 | WO2000006701A1 Improvement of cardiac function by mesenchymal stem cell transplantation |
| 02/10/2000 | WO2000006698A1 98 human secreted proteins |
| 02/10/2000 | WO2000006605A2 Heterominibodies |
| 02/10/2000 | WO2000006601A1 Isoforms of human calcium sensing receptor |
| 02/10/2000 | WO2000006598A1 Endogenous retrovirus tumor associated nucleic acids and antigens |
| 02/10/2000 | WO2000006588A1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 02/10/2000 | WO2000006587A1 New cofactors for methyltransferases |
| 02/10/2000 | WO2000006585A1 Medicine nitrate salts |